Looking back at Q1

What an action packed year 2023 is turning out to be. We started the year announcing our Hizentra app expansion to Japan, rang the Nasdaq opening bell, went to CES, JPM, and DTx West, and announced a new partnership with ixlayer, to name just a few highlights.

Here’s a video recap of our year to date:

2023 Q1 Key Highlights

Announcements

• CSL Behring’s Hizentra App expanded to Japan
• ixlayer joins the BrightInsight Ecosystem to Streamline Diagnosis and Improve Therapy
• BrightInsight renewed several key certifications, including ISO 13485:2016, MDSAP and the Hébergeur de Données de Santé

Awards

• BrightInsight named to the Fierce Medtech’s 2022 Fierce 15
• BrightInsight makes Forbes’ 2023 list of America’s Best Startup Employers

Events

• CES panel: Unparalleled health tech partnering opportunity for 2023 and beyond
• Attended JPM where we rang the Nasdaq opening bell, hosted a C-Suite Dinner and conducted a host of C-Suite Digital Health Interviews
• Attended DTx West where we hosted a dinner and joined a panel on digital health must haves

Key Publications

• MedCity News. Digital as the Differentiator for Biopharma and Medtech. Kal Patel CEO & Co-Founder, BrightInsight
• Nasdaq. Why Data Breaches Are Increasing, and 6 Ways Companies Can Avoid Them, Elena Ames, Data Privacy Officer, BrightInsight
• Forbes. How Agile Development Can Advance Digital Health In Pharma. Kal Patel CEO & Co-Founder, BrightInsight
• Forbes. Digital Health Predictions: Uncertainty Will Trigger Innovation In 2023. Kal Patel CEO & Co-Founder, BrightInsight